{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Topical&page=30", "query": { "intervention": "Topical", "page": 30 }, "page_size": 10 }, "pagination": { "page": 30, "page_size": 10, "total_count": 2650, "total_pages": 265, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Topical&page=31&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Topical&page=29&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-24T15:42:34.016Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01297400", "title": "Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Burns" ], "interventions": [ { "name": "Investigational Drug, MW-III", "type": "DRUG" }, { "name": "Silvadene® Cream 1% [Silver Sulfadiazine]", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Skingenix, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2022-03-11", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-03-16", "last_synced_at": "2026-10-24T15:42:34.016Z", "location_count": 4, "location_summary": "Phoenix, Arizona • Sacramento, California • Washington D.C., District of Columbia + 1 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Sacramento", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT01297400" }, { "nct_id": "NCT00996736", "title": "Mycotic Ulcer Treatment Trial I", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Corneal Ulcer", "Eye Infections, Fungal" ], "interventions": [ { "name": "Natamycin", "type": "DRUG" }, { "name": "Voriconazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 323, "start_date": "2010-04", "completion_date": "2012-07", "has_results": true, "last_update_posted_date": "2018-08-01", "last_synced_at": "2026-10-24T15:42:34.016Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00996736" }, { "nct_id": "NCT03644316", "title": "BandGrip® Closure of Surgical Incisions Following Arthroscopic Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Surgical Incision" ], "interventions": [ { "name": "BandGrip skin closure device", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "BandGrip", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2018-06-26", "completion_date": "2018-10-30", "has_results": false, "last_update_posted_date": "2019-07-10", "last_synced_at": "2026-10-24T15:42:34.016Z", "location_count": 1, "location_summary": "Des Moines, Iowa", "locations": [ { "city": "Des Moines", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT03644316" }, { "nct_id": "NCT02661958", "title": "Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "S6G5T-3", "type": "DRUG" }, { "name": "S6G5T-1", "type": "DRUG" }, { "name": "S6G5T-5", "type": "DRUG" }, { "name": "S6G5T-6", "type": "DRUG" }, { "name": "S6G5T-7", "type": "DRUG" }, { "name": "S6G5T-8", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sol-Gel Technologies, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": null, "sex": "ALL", "summary": "9 Years and older" }, "enrollment_count": 726, "start_date": "2016-05", "completion_date": "2017-10", "has_results": false, "last_update_posted_date": "2019-09-19", "last_synced_at": "2026-10-24T15:42:34.016Z", "location_count": 34, "location_summary": "Anaheim, California • Cerritos, California • Chula Vista, California + 27 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02661958" }, { "nct_id": "NCT03315689", "title": "Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alopecia Universalis (AU)", "Alopecia Totalis (AT)" ], "interventions": [ { "name": "Vehicle", "type": "DRUG" }, { "name": "ATI-50002", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aclaris Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2017-12-14", "completion_date": "2019-06-20", "has_results": true, "last_update_posted_date": "2020-07-02", "last_synced_at": "2026-10-24T15:42:34.016Z", "location_count": 2, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03315689" }, { "nct_id": "NCT01475955", "title": "Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Actinic Keratosis" ], "interventions": [ { "name": "Broad Area ALA 1-hour incubation", "type": "DRUG" }, { "name": "Broad Area ALA 2 hour incubation", "type": "DRUG" }, { "name": "broad area ALA 3-hour incubation", "type": "DRUG" }, { "name": "Spot ALA 2 hour incubation", "type": "DRUG" }, { "name": "Vehicle PDT", "type": "DRUG" }, { "name": "Blue Light Treatment", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "DUSA Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 235, "start_date": "2011-12", "completion_date": "2012-11", "has_results": true, "last_update_posted_date": "2016-10-28", "last_synced_at": "2026-10-24T15:42:34.016Z", "location_count": 13, "location_summary": "La Jolla, California • Los Angeles, California • San Diego, California + 10 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Boise", "state": "Idaho" }, { "city": "Arlington Heights", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01475955" }, { "nct_id": "NCT02142543", "title": "The Effect of 2-DeNT Oral Topical Powder on Minor Recurrent Aphthous Ulcer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Minor Recurrent Aphthous Stomatitis Lesions" ], "interventions": [ { "name": "2-DeNT powder", "type": "DRUG" }, { "name": "Placebo Comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Texas A&M University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "12 Years to 55 Years" }, "enrollment_count": 23, "start_date": "2012-03", "completion_date": "2012-12", "has_results": false, "last_update_posted_date": "2014-06-06", "last_synced_at": "2026-10-24T15:42:34.016Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02142543" }, { "nct_id": "NCT03381625", "title": "Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriasis", "Atopic Dermatitis" ], "interventions": [ { "name": "BMX-010", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioMimetix JV, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 139, "start_date": "2018-01-02", "completion_date": "2021-07-24", "has_results": false, "last_update_posted_date": "2021-10-05", "last_synced_at": "2026-10-24T15:42:34.016Z", "location_count": 10, "location_summary": "Encino, California • Denver, Colorado • Englewood, Colorado + 7 more", "locations": [ { "city": "Encino", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Englewood", "state": "Colorado" }, { "city": "Greenwood Village", "state": "Colorado" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03381625" }, { "nct_id": "NCT01597050", "title": "Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lupus Erythematosus, Discoid", "Lupus Erythematosus, Systemic" ], "interventions": [ { "name": "R932333", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rigel Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 54, "start_date": "2012-08", "completion_date": "2013-09", "has_results": true, "last_update_posted_date": "2016-07-14", "last_synced_at": "2026-10-24T15:42:34.016Z", "location_count": 12, "location_summary": "Los Angeles, California • Redwood City, California • South Bend, Indiana + 9 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Redwood City", "state": "California" }, { "city": "South Bend", "state": "Indiana" }, { "city": "Lake Success", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01597050" }, { "nct_id": "NCT03073967", "title": "Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "HSV Infection" ], "interventions": [ { "name": "Pritelivir", "type": "DRUG" }, { "name": "Investigator's choice", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AiCuris Anti-infective Cures AG", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 158, "start_date": "2017-05-08", "completion_date": "2025-11-11", "has_results": false, "last_update_posted_date": "2026-06-12", "last_synced_at": "2026-10-24T15:42:34.016Z", "location_count": 33, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 30 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03073967" } ] }